NSEMonitoring Agency Report6d ago · 12 Aug 2026, 06:36 pm
Monitoring Agency Report
DCX Systems Limited · DCXINDIA
✦ AI Summary
DCX Systems Limited has submitted a Monitoring Agency Report for the quarter ended June 30, 2026, as per SEBI Regulations and Monitoring Agency Agreement. The report confirms that the utilization of issue proceeds is in line with the objects of the issue.
Analysis Scores
Earnings Impact5/10
Growth Catalyst3/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk4/10
Liquidity Impact6/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Monitoring Agency Report for the quarter ended June 30, 2026
Attachments (1)
📄pdf
Download →
DCX_2022_12082026183621_MoniteringAgencyReport_June26.pdf
View document text
DCX SYSTEMS LIMITED
CIN: L31908KA2011PLC061686
An AS 9100D Certified
Regd. Off. Add.: Aerospace SEZ Sector, Plot Nos. 29,30 and Email:cs@dcxindia.co m
107, Hitech Defence and Aerospace Park, Kavadadasanahalli, Tel: 080-67119555
Bengaluru Rural – 562110, Karnataka, India. Web:www.dcxindia.com
August 12, 2026
BSE Limited National Stock Exchange of India Ltd
P J Towers Exchange Plaza, C-1, Block G
Dalal Street, Fort Bandra Kurla Complex, Bandra (E)
Mumbai – 400001 Mumbai – 400051
Scrip Code – 543650 Symbol – DCXINDIA
Dear Sir/Madam,
Sub: Monitoring Agency Report for the quarter ended June 30, 2026
Pursuant to Regulation 32(6) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015
and Regulation 41(4) of the SEBI (Issue of Capital and Disclosure Requirement) Regulations, 2015, we are
enclosing herewith the Monitoring Agency Report for the quarter ended June 30, 2026, issued by CARE
Ratings Limited, Monitoring Agency, with respect to utilization of proceeds of the Initial Public Offering (IPO)
and Qualified Institutional Placement (QIP) of the Company.
You are requested to take the same on your records.
Thanking you,
Yours faithfully,
For DCX Systems Limited
Gurumurthy Hegde
Company Secretary, Legal and Compliance Officer
Monitoring Agency Report
No. CARE/BRO/GEN/2026-27/1026
The Board of Directors
DCX Systems Limited
Aerospace SEZ Sector, Plot Nos.29,30 And 107,
Hitech Defence And Aerospace Park,
Kavadadasanahalli,
Bangalore Rural, Karnataka 562110
August 12, 2026
Dear Sir,
Monitoring Agency Report for the quarter ended June 30, 2026 - in relation to the Initial Public Offerings
(IPO) of DCX Systems Limited (“the Company”)
We write in our capacity of Monitoring Agency for the Fresh Issue of 1,93,23,671 shares for the amount aggregating to Rs.
400.00 crore of the Company and refer to our duties cast under 41 of the Securities & Exchange Board of India (Issue of
Capital & Disclosure Requirements) Regulations.
In this connection, we are enclosing the Monitoring Agency Report for the quarter ended June 30, 2026, as per aforesaid
SEBI Regulations and Monitoring Agency Agreement dated September 29, 2022.
Request you to kindly take the same on records.
Thanking you,
Yours faithfully,
Himanshu Jain
Associate Director
himanshu.jain@careedge.in
Report of the Monitoring Agency
Name of the issuer: DCX Systems Ltd
For quarter ended: June 30, 2026
Name of the Monitoring Agency: CARE Ratings Limited
(a) Deviation from the objects: No
(b) Range of Deviation: Nil
Declaration:
We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of
the issue based on the information provided by the Issuer and information obtained from sources believed by it to be
accurate and reliable. The MA does not perform an audit and undertakes no independent verification of any information/
certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA which
accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The views and opinions
expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever.
Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship between the MA
and any issuer or between the agency and any user of this report. The MA and its affiliates also do not act as an expert as
defined under Section 2(38) of the Companies Act, 2013.
The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report pertains
and may receive separate compensation for its ratings and certain credit related analyses. We confirm that there is no
conflict of interest in such relationship/interest while monitoring and reporting the utilization of the issue proceeds by the
issuer, or while undertaking credit rating or other commercial transactions with the entity.
We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments, where
applicable. There are certain sections of the report under the title “Comments of the Board of Directors”, that shall be
captured by the Issuer’s Management / Audit Committee of the Board of Directors subsequent to the MA submitting their
report to the issuer and before dissemination of the report through stock exchanges. These sections have not been reviewed
by the MA, and the MA takes no responsibility for such comments of the issuer’s Management/Board.
Signature:
Name and designation of the Authorized Signatory: Himanshu Jain
Designation of Authorized person/Signing Authority: Associate Director
1) Issuer Details:
Name of the issuer : DCX Systems Ltd
Name of the promoter : Dr. H S Raghavendra Rao, NCBG Holdings Inc and Raneal Technologies Private Limited
Industry/sector to which it belongs : Aerospace and Defence
2) Issue Details
Issue Period : October 31, 2022 to November 02, 2022
Type of issue (public/rights) : Public Fresh Issue
Type of specified securities : Equity Shares
IPO Grading, if any : Not applicable
Issue size (in crore) : Rs. 400.00 crore
3) Details of the arrangement made to ensure the monitoring of issue proceeds:
Source of information /
certifications considered by Comments of the Comments of the
Particulars Reply
Monitoring Agency for Monitoring Agency Board of Directors
preparation of report
There was change in the amount within the objects specified
in the offer document for which required shareholder
approval was taken. Also, purpose of investment in its
subsidiary Renal Advanced System Private Limited (RASPL)
RHP, Postal Ballot outcome
has been revised to loan repayment as against capital
published by the company on
Whether all utilization is as per the disclosures in the Offer expenditure mentioned in offer document.
No BSE on May 6, 2024, Board No comments
Document?
resolution dated February 12,
There has been a delay in the utilisation of GCP proceeds
2026
against the expected timeline of March 2026.
However, on February 12, 2026, the company has obtained
board resolution for the extension of the timeline in the
utilization of general corporate purpose till FY29.
As per postal ballot dated May 06, 2024, the company has
sought shareholder’s approval as per postal ballot dated May
06, 2024, for the reallocation of the funds as mentioned
below:
Whether shareholder approval has been obtained in case of Postal Ballot Outcome published The amount to be invested in its subsidiary Raneal Advanced
material deviations# from expenditures disclosed in the Yes by the company on BSE on May Systems Private Limited (RASPL) is reduced to Rs. 19.80 No comments
Offer Document? 6, 2024 crore from Rs. 44.88 crore. Consequently, the amount
towards general corporate purpose (GCP) increased from
Rs. 58.15 crore to Rs. 83.23 crore.
Whether the means of finance for the disclosed objects of No Postal Ballot outcome published None No comments
Source of information /
certifications considered by Comments of the Comments of the
Particulars Reply
Monitoring Agency for Monitoring Agency Board of Directors
preparation of report
the issue have changed? by the company BSE on May 6,
2024.
Monitoring agency report dated
Is there any major deviation observed over the earlier
No May 11, 2026, Board resolution No deviations. No comments
monitoring agency reports?
dated February 12, 2026.
Whether all Government/statutory approvals related to the Not
Management certificate, RHP No approvals were required as per RHP No comments
object(s) have been obtained? applicable
Whether all arrangements pertaining to technical Not
Management certificate, RHP No such collaboration was required as per RHP No comments
assistance/collaboration are in operation? applicable
Are there any favorable/unfavorable events affecting the
No Management certificate None No comments
viability of these object(s)?
The company has incurred los
[Showing first 8,000 characters — download PDF for full document]